Scientists discover how specific protein regions contribute to breast cancer

Abelacimab is under clinical development by Anthos Therapeutics and currently in Phase I for Venous (Vein) Thrombosis.

PTCL represents a diverse group of aggressive non-Hodgkin lymphomas, with patients at a high risk of disease relapse. Credit: Nemes Laszlo / Shutterstock. The National

All women ages 65 and older and at-risk postmenopausal women under 65 should be screened for osteoporosis to prevent fractures, according to a final recommendation